Latest Insider Transactions at Aileron Therapeutics Inc (ALRN)
This section provides a real-time view of insider transactions for Aileron Therapeutics Inc (ALRN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AILERON THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AILERON THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2024
|
James Brian Windsor President and CEO |
BUY
Open market or private purchase
|
Indirect |
400
+50.0%
|
$800
$2.25 P/Share
|
|
Jun 17
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,707
-0.27%
|
$14,121
$3.25 P/Share
|
|
Jun 14
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,900
-0.11%
|
$5,700
$3.3 P/Share
|
|
Jun 12
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,342
-0.27%
|
$28,026
$3.26 P/Share
|
|
Jun 11
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,752
-0.16%
|
$17,256
$3.3 P/Share
|
|
Jun 10
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,577
-0.54%
|
$28,731
$3.3 P/Share
|
|
Jun 07
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,740
-0.05%
|
$5,220
$3.28 P/Share
|
|
Jun 06
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,284
-0.12%
|
$12,852
$3.29 P/Share
|
|
Jun 05
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,291
-0.35%
|
$18,873
$3.3 P/Share
|
|
May 01
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,315
-0.07%
|
$81,260
$4.21 P/Share
|
|
Apr 30
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
90
-0.0%
|
$360
$4.98 P/Share
|
|
Apr 29
2024
|
University Of Texas > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,746
-0.1%
|
$42,984
$4.97 P/Share
|
|
Mar 05
2024
|
James Brian Windsor President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+21.93%
|
-
|
|
Dec 15
2023
|
James Brian Windsor President and CEO |
BUY
Open market or private purchase
|
Indirect |
225
+50.0%
|
$675
$3.37 P/Share
|
|
Nov 20
2023
|
James Brian Windsor President and CEO |
BUY
Open market or private purchase
|
Direct |
5,076
+49.77%
|
$5,076
$1.97 P/Share
|
|
Jan 08
2021
|
Muneer A Satter Director |
BUY
Open market or private purchase
|
Indirect |
9,000,000
+35.14%
|
$9,000,000
$1.1 P/Share
|
|
Apr 01
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,610
-0.98%
|
$20,610
$1.9 P/Share
|
|
Mar 29
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
106,540
-4.83%
|
$106,540
$1.85 P/Share
|
|
Mar 15
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
43,800
-1.95%
|
$43,800
$1.92 P/Share
|
|
Mar 14
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,800
-0.61%
|
$13,800
$1.88 P/Share
|
|
Mar 13
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
132,738
-5.54%
|
$265,476
$2.12 P/Share
|
|
Aug 20
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,388
-0.84%
|
$40,776
$2.3 P/Share
|
|
Aug 17
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,700
-0.36%
|
$17,400
$2.1 P/Share
|
|
Aug 16
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,808
-0.36%
|
$17,616
$2.1 P/Share
|
|
Aug 15
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,635
-0.11%
|
$5,270
$2.15 P/Share
|
|
Aug 14
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,300
-0.14%
|
$6,600
$2.26 P/Share
|
|
Aug 13
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,600
-0.07%
|
$3,200
$2.36 P/Share
|
|
Aug 10
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,615
-0.23%
|
$11,230
$2.44 P/Share
|
|
Aug 09
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
235
-0.01%
|
$470
$2.48 P/Share
|
|
Aug 08
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,000
-0.04%
|
$2,000
$2.78 P/Share
|
|
Aug 07
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,739
-0.07%
|
$3,478
$2.97 P/Share
|
|
Aug 06
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,942
-0.12%
|
$8,826
$3.02 P/Share
|
|
Aug 02
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,702
-0.19%
|
$14,106
$3.33 P/Share
|
|
Aug 01
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,181
-0.33%
|
$24,543
$3.22 P/Share
|
|
Jul 31
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,500
-0.18%
|
$13,500
$3.07 P/Share
|
|
Jul 30
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,000
-0.08%
|
$6,000
$3.27 P/Share
|
|
Jul 27
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,458
-0.26%
|
$19,374
$3.38 P/Share
|
|
Jul 26
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,937
-0.32%
|
$23,811
$3.63 P/Share
|
|
Jul 25
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,460
-0.5%
|
$37,380
$3.84 P/Share
|
|
Jul 24
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
700
-0.03%
|
$2,800
$4.11 P/Share
|
|
Jul 23
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,600
-1.21%
|
$122,400
$4.25 P/Share
|
|
Jul 17
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,500
-0.49%
|
$50,000
$4.71 P/Share
|
|
Jul 16
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
300
-0.01%
|
$1,500
$5.15 P/Share
|
|
Jul 05
2017
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
266,667
+9.49%
|
$4,000,005
$15.0 P/Share
|
|
Jul 05
2017
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,277,515
+50.0%
|
-
|